SS Innovations International, Inc.
NASDAQ:SSIIMedical - Devices
+$0.09 today
- Market cap
- $262.76M
- Beta
- 0.43
- P/E (TTM)
- -66.1
- EPS (TTM)
- -$0.05
Volume 0.08M
Average 0.05M
SSII Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
SS Innovations International, Inc.NASDAQ: SSII
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development dips below year-ago levels
Q1 FY2026 research & development of $995.44K fell 1.5% year over year, behind the +63.3% change in trailing-twelve-month research & development. Sequentially, it fell 28.4% from the prior quarter. Over 3 fiscal years it compounded at +253.7% a year.
Context
- Research & development amounted to 8.7% of revenue in FY2025, down 3.4 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -1.5% toward the trailing-twelve-month pace of +63.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 3.69M USD
- Year-over-year change
- +47.9%
- 4-year CAGR
- +679.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.69M | +47.9% |
| FY2024 | 2024-12-31 | 2.49M | +332.5% |
| FY2023 | 2023-12-31 | 576.17K | +591.8% |
| FY2022 | 2022-12-31 | 83.28K | +8228.2% |
| FY2021 | 2021-12-31 | 1K | — |
Research & Development vs competitors
How SSII compares with its peers on the latest reported figures
- SSII's LTM Mar 2026 research & development of $3.67M is the 5th highest of the 6 companies compared; the peer median is $9.43M.
- Its year-over-year change of +63.3% is the highest of 6, against a peer median of +4.9%.
- Research & development amounts to 7.6% of revenue for SSII, versus a peer median of 30.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.92B | +4.9% | +2.1% | 7.8% | |
| LTM Mar 2026 | $73.13M | +11.5% | +35.0% | 22.7% | |
| LTM Mar 2026 | $9.43M | -4.4% | -3.9% | 30.2% | |
| LTM Mar 2026 | $6.11M | -11.4% | -6.7% | 5814.3% | |
| LTM Mar 2026 | $3.67M | +63.3% | +253.7% | 7.6% | |
RRRichtech Robotics Inc. Class B Common Stock | LTM Dec 2025 | $2.4M | +43.4% | +11.1% | 48.6% |
| Peer median (excluding SSII) | $9.43M | +4.9% | +2.1% | 30.2% | |
Competitors are the stored peer set for SSII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 1.46M | 5.88M | 20.65M | 42.48M |
| Cost of Revenue | 18.79K | 968.72K | 5.17M | 12.2M | 22.94M |
| Gross Profit | (18.79K) | 489.59K | 713.45K | 8.45M | 19.54M |
| Gross Margin | — | 33.6% | 12.1% | 40.9% | 46.0% |
| Research & Development | 1K | 83.28K | 576.17K | 2.49M | 3.69M |
| Selling, General & Admin | 1.39M | 6.09M | 20.81M | 24.5M | 22.98M |
| Operating Expenses | 1.39M | 6.17M | 21.38M | 27.43M | 27.74M |
| Depreciation & Amortization | 18.79K | 128.9K | 162.62K | 436.01K | 1.08M |
| EBITDA | (1.47M) | (5.31M) | (20.26M) | (17.74M) | (5.98M) |
| EBITDA Margin | — | -364.2% | -344.5% | -85.9% | -14.1% |
| Operating Income | (1.41M) | (5.68M) | (20.67M) | (18.98M) | (8.19M) |
| Operating Margin | — | -389.4% | -351.5% | -91.9% | -19.3% |
| Interest Income | 118 | 239.73K | 129.76K | 798K | 1.14M |
| Interest Expense | 0 | 162K | 523.36K | 973.24K | 1.11M |
| Other Income / Expenses | (77.27K) | 77.73K | (273.6K) | (175.24K) | 33.09K |
| Income Before Tax | (1.48M) | (5.6M) | (20.94M) | (19.15M) | (8.16M) |
| Pre-Tax Margin | — | -384.1% | -356.2% | -92.7% | -19.2% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 3.97M |
| Net Income | (1.48M) | (5.6M) | (20.94M) | (19.15M) | (12.13M) |
| Net Margin | — | -384.1% | -356.2% | -92.7% | -28.5% |
| EPS (Basic) | (0.52) | (1.41) | (0.16) | (0.11) | (0.06) |
| EPS (Diluted) | (0.52) | (1.41) | (0.16) | (0.10) | (0.06) |
| Weighted Avg Shares | 2.85M | 3.98M | 128.45M | 170.78M | 190.01M |
| Weighted Avg Shares (Diluted) | 2.85M | 3.98M | 128.45M | 181.89M | 198.7M |
SS Innovations International, Inc.
NASDAQ:SSII
Intrinsic Alpha fair value
Locked
Current Price
$1.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.